Award

Skiniotis has ‘outstanding talent,’ ‘technical prowess’

He won the ASBMB's Earl and Thressa Stadtman Scholar Award
Ulli Hain
By Ulli Hain
March 1, 2016

Georgios Skiniotis, associate professor of biological chemistry at the University of Michigan Life Sciences Institute and the University of Michigan Medical School, is the co-winner of the 2016 American Society for Biochemistry and Molecular Biology Earl and Thressa Stadtman Scholar Award for his innovative use of electron microscopy. The award, given every other year, honors outstanding researchers with fewer than 10 years of post-postdoctoral experience.

Skiniotis-Georgios-235x293.jpg
“It’s an honor for our lab to receive an award named after such pioneers as Earl and Thressa Stadtman. Cryo-EM is a fast evolving technology poised to shed light on the mechanisms underlying complex cellular processes; in its application we strive to embody and transmit the tradition of excellent basic science and passion for discovery that is the Stadtmans’ legacy.” — Georgios Skiniotis

To initiate intracellular signaling, G-protein–coupled receptors, or GPCRs, on the surface of our cells transmit diverse information, such as hormones, neurotransmitters and light from our environment. Skiniotis pioneered the use of single-particle electron microscopy, or EM, to study GPCRs in complex with their cognate G proteins. These structures were groundbreaking in terms of both the small size of the analyzed proteins and the surprising amount of movement within the receptor-bound G protein.

In her letter nominating Skiniotis for the award, colleague Janet L. Smith at the University of Michigan said Skiniotis’ “rare combination of outstanding talent in biochemistry and technical prowess with electron microscopy has allowed him to push the boundaries of EM analysis and obtain structural information from molecules and assemblies formerly considered too small for single particle reconstruction.” She added that he has also “fearlessly tackled problems of great biological and chemical importance.”

Skiniotis’ work has important implications for human disease, because understanding the structural mechanism behind GPCRs allows for the development of novel therapies that target these receptors.

During his dissertation work at the European Molecular Biology Laboratory, Skiniotis developed a novel technique for labeling proteins for cryo-EM analysis. He used this technique to study the movement and processivity of the motor protein kinesin. He demonstrated that tubulin is not just a track for kinesin but rather actively modulates kinesin movement.

Most recently, Skiniotis applied his EM expertise to better understand polyketide synthesis by the multidomain polyketide synthases, or PKSs. Polyketides are naturally produced and structurally complex compounds. Many polyketides have antimicrobial, antifungal or immunosuppressant activity, and nearly a third of pharmaceuticals are based on or inspired by polyketides. By understanding the mechanism behind these polyketide factories, it may be possible to bioengineer PKSs to create novel antibiotics.

Skiniotis recently published a stunning series of structures of a PKS module in the journal Nature. In his letter supporting Skiniotis' nomination, Stephen Harrison at Harvard Medical School, who interacted with Skiniotis when the latter was a postdoctoral fellow at the school, described the series as “triumphs of structural biology.” The structures not only represent the complete enzymatic cycle of a full PKS module for the first time but also detail an unexpected architecture. Unlike the related mammalian fatty acid synthase, the bacterial PKS module forms an arch-shaped dimer that creates a single chamber for the acyl carrier protein to deliver its substrate to the different active sites within the module.

Skiniotis adds the Earl and Thressa Stadtman Scholar Award to an already impressive résumé. He was named a Pew Scholar in Biomedical Sciences in 2011 and received the Presidential Early Career Award for Scientists and Engineers in 2012.

Watch his award lecture, “Molecular choreography of an antibiotic assembly line,” below.

 

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition weekly.

Learn more
Ulli Hain
Ulli Hain

Ulli Hain received her Ph.D. from the Johns Hopkins University. She is a science writer at Palladian Partners, Inc.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Professorships for Booker; scholarship for Entzminger
Member News

Professorships for Booker; scholarship for Entzminger

Feb. 3, 2025

Squire Booker has been appointed to two honorary professorships at Penn State University. Inayah Entzminger received a a BestColleges scholarship to support their sixth year in the biochemistry Ph.D. program at CUNY.

Microbiology Society names 2025 award winners
Award

Microbiology Society names 2025 award winners

Jan. 27, 2025

Nikea Pittman and Chelsey Spriggs receive MicroSoc's Equality, Diversity and Inclusion Prize, and Cesar de la Fuente gets the Fleming Prize for an early-career researcher.

Q&A with 2024 PROLAB winner Daniel Careno
Interview

Q&A with 2024 PROLAB winner Daniel Careno

Jan. 26, 2025

Learn about Careno’s experience investigating circadian rhythms in Ariel Bazzini’s lab at the Stowers Institute.

RNA binding proteins with benefits
Research Spotlight

RNA binding proteins with benefits

Jan. 22, 2025

Blanton Tolbert studies the biochemical mechanisms of RNA virus replication while working to make science more accessible, and more interesting, for all people.

Honors for Bai, Thompson and Visweswariah
Member News

Honors for Bai, Thompson and Visweswariah

Jan. 20, 2025

An honorary professorship for Bai, Thompson named endowed chair and Visweswariah is IUBMB's president-elect.

From antibiotic resistance to an antibody targeting immune cells
Profile

From antibiotic resistance to an antibody targeting immune cells

Jan. 15, 2025

MOSAIC scholar Diego Pedroza got his start in chemistry, then moved to molecular biology, endocrinology and testing cancer drugs — “something that could truly make a difference.”